Glenmark recalls 120mg Diltiazem capsules due to failed dissolution specifications. Rx-only medication may not release properly in the body. Contact for return instructions.
“Glenmark Diltiazem Capsules Recall: Failed Dissolution Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32737-glenmark-diltiazem-capsules-recall-failed-dissolution-risk. Based on FDA recall #D-0472-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0472-2024%22&limit=1).
The FDA announced on April 17, 2024, that Glenmark Pharmaceuticals Inc., USA is recalling Diltiazem Hydrochloride Extended-Release Capsules due to failed dissolution specifications. The recall affects 3,264 bottles distributed nationwide.
How to tell if you have it
Brand: Glenmark
Product: Diltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Twice-a-Day Dosage, 100 Capsules per bottle, Rx Only
NDC: 68462-562-01
Lot #: 17221312
Expiration Date: 5/31/2024
The hazard
The product failed dissolution specifications. The recall is classified as Class II.
Context
GovInfoNow's records show Glenmark Pharmaceuticals Inc., USA has 54 other recalls on record since November 20, 2017. Other recent recalls of similar products include Glenmark Azelaic Acid Gel 15% Recall (July 23, 2026), Glenmark Alyacen Birth Control Tablets Recall (May 27, 2026), and Glenmark Ondansetron Tablets Recall (December 30, 2025). Other recent recalls of similar products include Sun Pharmaceutical Lisdexamfetamine Capsules Recall (October 28, 2025), Inventia Healthcare Chlorthalidone Tablets Recall (June 5, 2026), and Supernus Trokendi XR 50mg Capsules: Failed Dissolution Specifications Recall (August 31, 2026).
How to tell if you have this one
Check for the product name 'Diltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Twice-a-Day Dosage, 100 Capsules per bottle, Rx Only'. Look for the lot number 17221312 and expiration date 5/31/2024.
Brand
Glenmark
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Verify the product name, lot number 17221312, and expiration date 5/31/2024 on the bottle.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 14 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0472-2024 (April 17, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0472-2024 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.